Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Infliximab-induced lupus erythematosus in a case of ulcerative colitis].
Nishikawa J, Miyazaki T, Suzuki N, Itaya Y, Yamawaki H, Mihara H, Hasumoto Y, Fujinami H, Ogawa K, Hosokawa A, Kudo T, Sugiyama T. Nishikawa J, et al. Among authors: ogawa k. Nihon Shokakibyo Gakkai Zasshi. 2011 Sep;108(9):1535-9. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21891993 Japanese.
Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.
Ogawa K, Hosokawa A, Ueda A, Saito S, Mihara H, Ando T, Kajiura S, Terada M, Tsukioka Y, Horikawa N, Kobayashi T, Note M, Sawasaki K, Fukuoka J, Sugiyama T. Ogawa K, et al. Gastroenterol Res Pract. 2012;2012:640401. doi: 10.1155/2012/640401. Epub 2012 Feb 15. Gastroenterol Res Pract. 2012. PMID: 22474446 Free PMC article.
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Ueda A, Hosokawa A, Ogawa K, Yoshita H, Mihara H, Ando T, Kajiura S, Fujinami H, Nishikawa J, Minemura M, Terada M, Kobayashi T, Horikawa N, Yabushita K, Note M, Sugiyama T. Ueda A, et al. Among authors: ogawa k. Anticancer Res. 2013 Nov;33(11):5107-11. Anticancer Res. 2013. PMID: 24222156
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Kajiura S, Hosokawa A, Yoshita H, Ueda Y, Ueda A, Mihara H, Ando T, Fujinami H, Nishikawa J, Ogawa K, Minemura M, Sugiyama T. Kajiura S, et al. Among authors: ogawa k. Am J Clin Oncol. 2016 Feb;39(1):13-7. doi: 10.1097/COC.0000000000000018. Am J Clin Oncol. 2016. PMID: 24322336 Clinical Trial.
5,717 results